Showing 1070 – 1080 of 1303 results
-
Taysha Gene Therapies Inc Initiation
William Blair & Company initiated research coverage of Taysha Gene Therapies, Inc. (TSHA $29.10), which is focused on developing and commercializing AAV gene therapies for the treatment of monogenic CNS disorders in rare and large patient populations.
-
PFAS Solutions The Potential Impact of Loper Bright
In this episode of William Blair Thinking Presents, Tim Mulrooney, group head of global services, follows up on his last episode about the PFAS market to detail how the recent Supreme Court ruling known as Loper Bright could have far-reaching implications for all types of regulations, including environmental ones like PFAS.
-
On the Ground and in the Cloud Observability and AIOps
William Blair tech analyst Jake Roberge joins the show to discuss the observability and AIOps software markets, including the increasingly important role these platforms are playing for businesses of all sizes, why they are gaining momentum over legacy monitoring tools, and some of the key trends he’s seeing in the market.
-
Hoban-Gleason-Minturn Quarterly
Read our quarterly global market review and outlook.
-
Sweetgreen Inc Initiation
William Blair initiated research coverage of Sweetgreen, Inc. (SG $30.46). Sweetgreen is a rapidly growing category leader in healthy fast-casual restaurants, featuring a digitally led customer service model alongside a farm-to-table plant-forward menu.
-
HashiCorp Inc Initiation
William Blair initiated research coverage of HashiCorp, Inc. (HCP $90.54), which provides infrastructure automation software solutions to enterprises around the world.
-
Initiation
William Blair initiated research coverage of CSG Systems International, Inc. (CSGS $55.18), a revenue and customer management, customer engagement, and monetization solution provider that enables clients to monetize relationships with the end-customer.
-
UserTesting Inc Initiation
William Blair initiated research coverage of UserTesting, Inc. (USER $8.13), which provides customers with a leading software platform for human insights and video-first user feedback.
-
Braze Inc Initiation
William Blair initiated research coverage of Braze, Inc. (BRZE $66.95). Braze is a leading customer engagement platform that deploys a streaming data architecture to orchestrate, personalize, and deliver marketing campaigns to customers.
-
Bionomics Limited Initiation
William Blair initiated research coverage of Bionomics Limited (BNOX $11.52), a clinical-stage biopharma company based in Australia with U.S. operations developing small-molecule ion channel modulators to treat central nervous system disorders.